Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shoulder fix devices pass safety check in 214 patients

NCT ID NCT05584553

Disease control Sponsor: Zimmer Biomet Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked back at 214 patients who had shoulder surgery using two specific devices (ToggleLoc and JuggerLoc) to reattach soft tissue to bone. The goal was to see if the devices helped the tissue heal properly and were safe. Results showed most patients had good healing with few needing repeat surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ToggleLoc 2.9mm and JuggerLoc soft tissue fixation devices
What this could lead to
If successful, this confirms these devices are safe and effective for reattaching soft tissue to bone in the shoulder, supporting their continued use.
What could go wrong
This is a retrospective study without a comparison group, so results may be biased. It only looks back at past surgeries, not testing new approaches.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

214 people

The number who actually took part.

Started

Dec 2022

Finished

Jun 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients who had required a soft tissue to bone fixation in the shoulder with the ToggleLoc 2.9 mm and/or the JuggerLoc Soft Tissue devices according to Zimmer Biomet's Instruction for Use (IFU) and and who meet all the inclusions criteria and none of the exclusions criteria.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients that received the ToggleLoc 2.9 mm and/or the JuggerLoc Soft Tissue devices for soft tissue to bone fixation in the shoulder. * Patients 18 years or older and skeletally mature. * Patients capable of understanding the surgeon's explanations and following his/her instructions, able and willing to participate in the follow-up program and who gave consent to take part in the study. Exclusion Criteria: * Infection. * Patient conditions including blood supply limitations, and insufficient quantity or quality of bone or soft tissue. * Patients with mental or neurologic conditions who are unwilling or incapable of following postoperative care instructions. * Foreign body sensitivity. Where material sensitivity is suspected, testing is to be completed prior to implantation of the device. * Patients who are unwilling or unable to give consent, or to comply with the follow-up program. * Patients who have any condition that would in the judgment of the Investigator place the patient at undue risk or interfere with the study. * Patient is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, a known alcohol or drug abuser, anticipated to be non-compliant). * Off-label use.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acromioclavicular; dislocation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Bankart Lesions bicipital tenosynovitis Joint Dislocations rotator cuff syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acromioclavicular; dislocation Bankart lesions Biceps tendon disorder Capsular shift/capsulolabral reconstruction Deltoid repair Rotator cuff tear repair Slap lesion

Contacts and locations

Locations

  • Advanced Bone and Joint

    City of Saint Peters, Missouri, 63376, United States

  • Centro Médico Quirónsalud

    Alicante, 03184, Spain

  • Hospital Universitario Quirónsalud

    Madrid, 28223, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.